BBCMF (Lir Life Sciences) Change In Receivables: $0.01 Mil (TTM As of Jan. 2026)


BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences Change In Receivables?

Lir Life Sciences BBCMF 15 Change In Receivables is $0.01 Mil as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

Lir Life Sciences's change in receivables for the quarter that ended in Jan. 2026 was $-0.03 Mil. It means Lir Life Sciences's Accounts Receivable increased by $0.03 Mil from Oct. 2025 to Jan. 2026 .

Lir Life Sciences's change in receivables for the fiscal year that ended in Apr. 2025 was $0.01 Mil. It means Lir Life Sciences's Accounts Receivable declined by $0.01 Mil from Apr. 2024 to Apr. 2025 .

Lir Life Sciences's Accounts Receivable for the quarter that ended in Jan. 2026 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Lir Life Sciences's liquidation value for the three months ended in Jan. 2026 was $0.61 Mil.

Lir Life Sciences  (OTCPK:BBCMF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Lir Life Sciences's Days Sales Outstanding for the quarter that ended in Jan. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0*91
=

2. In Ben Graham's calculation of liquidation value, Lir Life Sciences's accounts receivable are only considered to be worth 75% of book value:

Lir Life Sciences's liquidation value for the quarter that ended in Jan. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.669-0.057+0.75 * 0+0.5 * 0
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Change In Receivables Related Terms

Lir Life Sciences Change In Receivables Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Change In Receivables Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
Change In Receivables
0.00 0.01

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Change In Receivables Get a 7-Day Free Trial -0.09 0.01 -0.01 0.03 -0.03
BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $0.01 Mil mean?
Lir Life Sciences (BBCMF) has a Change In Receivables of $0.01 Mil as of Jan. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Lir Life Sciences and its competitors.
Is Lir Life Sciences' Change In Receivables too high?
Lir Life Sciences' current Change In Receivables is $0.01 Mil. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Change In Receivables compare to VRTX and REGN?
Lir Life Sciences' Change In Receivables of $0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Biotechnology company?
A good Change In Receivables depends on the Biotechnology industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Lir Life Sciences and its competitors. Lir Life Sciences's current Change In Receivables is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Change In Receivables of $0.01 Mil. The current Change In Receivables is $0.01 Mil. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Change In Receivables is $0.01 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price